Azilsartan medoxomil, Cilnidipine

Azilsartan Medoxomil is a unique angiotensin II receptor blocker (ARB) that works in the blood vessels, helping reduce blood pressure by relaxing the tightness in blood vessels. Alongside, Cilnidipine is a calcium- channel blocker (CCB). It prevents calcium from getting into the muscle cells of the wall of blood vessels, thus relaxing vessels and lowering blood pressure, making it an ideal combination product for treating high blood pressure.
What it is used for:
As a combination of Azilsartan Medoxomil and Cilnidipine, this medication (ARB- CCB) demonstrates effective and well tolerated blood pressure-lowering activities. This dual action contributes to its broad application area, primarily for the treatment of those with hypertension (higher than normal blood pressure levels). Hypertension is strongly associated with the risk of cardiac events, so by lowering blood pressure, this combination medication seeks to reduce this risk, improving over all heart health.
Healthcare professionals may recommend taking this medication after careful discussion of the benefits, risks, cost, and other available treatment choices. It’s crucial to follow up with a healthcare professional regularly since blood pressure needs are individual specific. Patients should have their blood pressure monitored frequently using a device known as a sphygmomanometer before and during the use of this medication; this ensures optimal blood-pressure management.
The medication is to be taken orally only as prescribed, with care to not miss or skip dose. If you are unsatisfied with this product or have allergic reactions to its components – Azilsartan and cilnidipine, please check with your doctor immediately. Common side effects can include dizziness, headache, swelling mainly in the legs and ankles, and inability to retain urine. Seek medical treatment if these symptoms worsen or not improve within 1 month.